Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07486960
Brief Summary:
This study assesses the efficacy, safety, and tolerability of tulisokibart (MK-7240) in adult participants with active Psoriatic Arthritis.
Study:
NCT07486960
Study Brief:
Protocol Section:
NCT07486960